Reference
- Munson MJ, Mathai BJ, Ng MYW, et al. GAK and PRKCD are positive regulators of PRKN-independent mitophagy. Nat Commun. 2021;12:6101.
Autophagic Punctum
GAK and PRKCD kinases regulate basal mitophagy
Michael J. Munsona Division of Biochemistry, Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway;b Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway;c Advanced Drug Delivery, Pharmaceutical Sciences, Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
https://orcid.org/0000-0001-9927-8157View further author information
https://orcid.org/0000-0001-9927-8157View further author information, Benan J. Mathaia Division of Biochemistry, Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway;b Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norwayhttps://orcid.org/0000-0002-9549-2073View further author information
https://orcid.org/0000-0002-9549-2073View further author information, Matthew Yoke Wui Nga Division of Biochemistry, Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway;b Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norwayhttps://orcid.org/0000-0001-8122-6607View further author information
https://orcid.org/0000-0001-8122-6607View further author information, Laura Trachsel-Monchoa Division of Biochemistry, Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway;b Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norwayhttps://orcid.org/0000-0002-8525-7790View further author information
https://orcid.org/0000-0002-8525-7790View further author information, Laura R. de la Ballinaa Division of Biochemistry, Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway;b Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norwayhttps://orcid.org/0000-0001-5363-7433View further author information
https://orcid.org/0000-0001-5363-7433View further author information & Anne Simonsena Division of Biochemistry, Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway;b Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway;d Department of Molecular Cell Biology, The Norwegian Radium Hospital Montebello, Oslo, NorwayCorrespondence[email protected]
https://orcid.org/0000-0003-4711-7057View further author information
https://orcid.org/0000-0003-4711-7057View further author information